ID   Mfh-val2
AC   CVCL_LF73
SY   mfh-val2; Malignant fibrous histiocytoma-Valencia 2
DR   Wikidata; Q54905393
RX   PubMed=28676915;
CC   Doubling time: 56 hours (PubMed=28676915).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=28676915).
ST   Source(s): PubMed=28676915
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D21S11: 28,31.2
ST   D5S818: 12
ST   D7S820: 9,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
RX   PubMed=28676915; DOI=10.1007/s10616-017-0112-5; PMCID=PMC5507838;
RA   Gil-Benso R., Megias J., San-Miguel T., Pinto S., Callaghan R.C.,
RA   Lopez-Gines C., Cerda-Nicolas M.;
RT   "Characterization of the new human pleomorphic undifferentiated
RT   sarcoma TP53-null cell line mfh-val2.";
RL   Cytotechnology 69:539-550(2017).
//